Asset
Aflibercept
Revenue
No revenue reported in loaded filings.
Clinical trials (1)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT00921661 | phase1 | completed | 2009-06-01 | 2012-06-01 | Sanofi | Study of Intravenous Aflibercept in Combination With FOLFIRI in Japanese Patients With Metastatic Colorectal Cancer |
FDA applications (0)
This company has no applications containing this asset.